found that GLP-1R activation reduced tumor growth and metastatic potential by inhibiting ERK1/2 and AKT phosphorylation, lowering MMP-2 and MMP-9 expression, and increasing E-cadherin
In vitro studies confirmed its compatibility, reduced oxidative stress, enhanced insulin production, and increased glucose uptake [129]
Include the dates, the duration, and the results
USA 101 , 1013210136 (2004)
While treatment varies by severity, common approaches include: Dietary Modifications Small, frequent meals Low-fat, low-fiber diet Soft or liquid foods Avoid raw vegetables, fatty meats, and high-fiber grains Medications Prokinetics to improve stomach motility Anti-nausea medications Acid reduction therapies (if needed) Advanced Interventions Feeding tubes (severe cases) IV hydration Gastric electrical stimulation Surgery (rare) Important: Stopping the GLP-1 drug may improve symptoms but many patients continue to experience symptoms long-term